日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The RANK/RANKL axis controls vascular dynamics in the bone marrow

RANK/RANKL轴控制骨髓中的血管动力学

Kaneko, Takeshi; Yari, Shinya; Kikuta, Junichi; Omatsu, Yoshiki; Seno, Shigeto; Kikuchi, Sumire; Sato, Kazuma; Fujii, Kentaro; Sudo, Takao; Hasegawa, Tetsuo; Furuta, Kunimaro; Guo, Qianqian; Ibrahim, Samar H; Muraoka, Kosuke; Okada, Yoshiaki; Kubota, Yoshiaki; Okuzaki, Daisuke; Kobayashi, Yasuhiro; Kumanogoh, Atsushi; Udagawa, Nobuyuki; Nagasawa, Takashi; Penninger, Josef M; Ishii, Masaru

High HER2 Intratumoral Heterogeneity Is Resistant to Anti-HER2 Neoadjuvant Chemotherapy in Early Stage and Locally Advanced HER2-Positive Breast Cancer

HER2 肿瘤内异质性高是早期和局部晚期 HER2 阳性乳腺癌对抗 HER2 新辅助化疗耐药的原因

Hatano, Takaaki; Tanei, Tomonori; Seno, Shigeto; Sota, Yoshiaki; Masunaga, Nanae; Mishima, Chieko; Tsukabe, Masami; Yoshinami, Tetsuhiro; Miyake, Tomohiro; Shimoda, Masafumi; Shimazu, Kenzo

Association between tranexamic acid administration and mortality based on the trauma phenotype: a retrospective analysis of a nationwide trauma registry in Japan

基于创伤表型的氨甲环酸给药与死亡率之间的关联:一项日本全国创伤登记的回顾性分析

Tachino, Jotaro; Seno, Shigeto; Matsumoto, Hisatake; Kitamura, Tetsuhisa; Hirayama, Atsushi; Nakao, Shunichiro; Katayama, Yusuke; Ogura, Hiroshi; Oda, Jun

High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer

HER2肿瘤内异质性高是早期和局部晚期HER2阳性乳腺癌预后不良的预测因素

Tanei, Tomonori; Seno, Shigeto; Sota, Yoshiaki; Hatano, Takaaki; Kitahara, Yuri; Abe, Kaori; Masunaga, Nanae; Tsukabe, Masami; Yoshinami, Tetsuhiro; Miyake, Tomohiro; Shimoda, Masafumi; Matsuda, Hideo; Shimazu, Kenzo

Plasma proteomics profile-based comparison of torso versus brain injury: A prospective cohort study

基于血浆蛋白质组学特征的躯干损伤与脑损伤比较:一项前瞻性队列研究

Tachino, Jotaro; Togami, Yuki; Matsumoto, Hisatake; Matsubara, Tsunehiro; Seno, Shigeto; Ogura, Hiroshi; Oda, Jun

A single fast Hebbian-like process enabling one-shot class addition in deep neural networks without backbone modification

一种快速的类赫布过程,无需修改主干网络即可在深度神经网络中一次性添加类别。

Hosoda, Kazufumi; Nishida, Keigo; Seno, Shigeto; Mashita, Tomohiro; Kashioka, Hideki; Ohzawa, Izumi

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients

血浆中WFDC2、CHI3L1和KRT19的组合定义了一种与COVID-19危重患者预后相关的临床实用分子表型

Ebihara, Takeshi; Matsubara, Tsunehiro; Togami, Yuki; Matsumoto, Hisatake; Tachino, Jotaro; Matsuura, Hiroshi; Kojima, Takashi; Sugihara, Fuminori; Seno, Shigeto; Okuzaki, Daisuke; Hirata, Haruhiko; Ogura, Hiroshi

MPP6 stimulates both RRP6 and DIS3 to degrade a specified subset of MTR4-sensitive substrates in the human nucleus

MPP6 可刺激 RRP6 和 DIS3 降解人细胞核中特定的 MTR4 敏感底物子集。

Fujiwara, Naoko; Shigemoto, Maki; Hirayama, Mizuki; Fujita, Ken-Ichi; Seno, Shigeto; Matsuda, Hideo; Nagahama, Masami; Masuda, Seiji

Development of clinical phenotypes and biological profiles via proteomic analysis of trauma patients

通过对创伤患者进行蛋白质组学分析,构建临床表型和生物学特征模型

Tachino, Jotaro; Matsumoto, Hisatake; Sugihara, Fuminori; Seno, Shigeto; Okuzaki, Daisuke; Kitamura, Tetsuhisa; Komukai, Sho; Kido, Yoshiyuki; Kojima, Takashi; Togami, Yuki; Katayama, Yusuke; Nakagawa, Yuko; Ogura, Hiroshi

Determining homologous recombination deficiency scores with whole exome sequencing and their association with responses to neoadjuvant chemotherapy in breast cancer

利用全外显子组测序确定同源重组缺陷评分及其与乳腺癌新辅助化疗疗效的相关性

Kim, Seung Jin; Sota, Yoshiaki; Naoi, Yasuto; Honma, Keiichiro; Kagara, Naofumi; Miyake, Tomohiro; Shimoda, Masafumi; Tanei, Tomonori; Seno, Shigeto; Matsuda, Hideo; Noguchi, Shinzaburo; Shimazu, Kenzo